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Abstract
The hippocampus is a heterogeneous structure, comprising histologically distinguishable subﬁelds. These subﬁelds are
differentially involved in memory consolidation, spatial navigation and pattern separation, complex functions often impaired
in individuals with brain disorders characterized by reduced hippocampal volume, including Alzheimer’s disease (AD) and
schizophrenia. Given the structural and functional heterogeneity of the hippocampal formation, we sought to characterize the
subﬁelds’ genetic architecture. T1-weighted brain scans (n= 21,297, 16 cohorts) were processed with the hippocampal
subﬁelds algorithm in FreeSurfer v6.0. We ran a genome-wide association analysis on each subﬁeld, co-varying for whole
hippocampal volume. We further calculated the single-nucleotide polymorphism (SNP)-based heritability of 12 subﬁelds, as
well as their genetic correlation with each other, with other structural brain features and with AD and schizophrenia. All
outcome measures were corrected for age, sex and intracranial volume. We found 15 unique genome-wide signiﬁcant loci
across six subﬁelds, of which eight had not been previously linked to the hippocampus. Top SNPs were mapped to genes
associated with neuronal differentiation, locomotor behaviour, schizophrenia and AD. The volumes of all the subﬁelds were
estimated to be heritable (h2 from 0.14 to 0.27, all p < 1 × 10–16) and clustered together based on their genetic correlations
compared with other structural brain features. There was also evidence of genetic overlap of subicular subﬁeld volumes with
schizophrenia. We conclude that hippocampal subﬁelds have partly distinct genetic determinants associated with speciﬁc
biological processes and traits. Taking into account this speciﬁcity may increase our understanding of hippocampal
neurobiology and associated pathologies.
Introduction
The hippocampus has a key role in learning, memory
and spatial navigation [1]. It is known to be particularly
vulnerable to pathological conditions and implicated
in several major brain disorders, most notably schizophrenia
[2, 3] and Alzheimer’s disease (AD) [4].
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The breadth of ﬁndings regarding the role of the hippo-
campus in behaviour and its nonspeciﬁc association with a
range of brain disorders may result from the fact that it is a
heterogeneous structure, consisting of cytoarchitecturally
distinct subﬁelds which subserve distinct functions [5, 6].
Lesion studies and intrinsic connectivity patterns support a
dichotomy between an anterior section, attributed a role in
anxiety-related behaviours, and more posterior regions,
important for spatial processing and cognition [7]. There is
also a gradient of extrinsic connectivity to both cortical and
subcortical regions across the longitudinal axis superimposed
on the hippocampal intrinsic connectivity organization, illus-
trating the complexity of hippocampal biology [8]. First-
episode schizophrenia has been most strongly associated with
the cornu ammonis (CA)1 region and the subiculum in the
anterior hippocampus [9, 10], although with longer illness
duration more posterior regions also appear affected [11]. AD
is also thought to be primarily associated with volume
reductions in CA1 and subiculum, with the dentate gyrus
(DG) and CA3 relatively spared [12, 13], although opposing
ﬁndings have been reported [14].
Imaging genetics studies have ﬁrmly established that
hippocampal volume is a highly polygenic trait. Given the
differences in cytoarchitecture, connectivity patterns and
functions of the hippocampal subregions, it is likely to be
that the volumes of the different subﬁelds also have dif-
ferent genetic determinants. This is supported by gene
expression studies documenting strict boundaries between
subregions with respect to their transcriptional proﬁles
[15, 16]. Genome-wide association studies (GWAS) have
identiﬁed and subsequently replicated several single-
nucleotide polymorphisms (SNPs) that are signiﬁcantly
associated with whole hippocampal volume [17–19]. These
GWAS also showed that top SNPs have localized effects on
speciﬁc subcortical brain regions [18] and speciﬁc hippo-
campal subﬁelds [19] rather than global effects. A follow-
up study failed to ﬁnd evidence of genetic overlap between
schizophrenia risk and whole hippocampal volume [20].
This may be partly explained by a lack of anatomical spe-
ciﬁcity in the volumetric estimates, suggesting that a more
granular approach may be required.
Recently, Iglesias et al. [5] constructed a new atlas of the
hippocampus, based on ultra-high-resolution magnetic
resonance imaging (MRI) data using ex vivo samples [5].
This atlas has been combined with an automated segmen-
tation algorithm and released as part of the popular neu-
roimaging software suite FreeSurfer v6. An initial analysis
of this new software in several large-scale neuroimaging
datasets established that all subﬁelds are highly heritable,
and that 11 of the 12 subﬁelds show strong test–retest and
transplatform reliability [21].
In this study, we explored the genetic architecture of
each hippocampal subﬁeld volume, as segmented by the
algorithm released with FreeSurfer v6. We hypothesized
that the greater speciﬁcity of these measures, compared with
whole hippocampal volume, should reduce noise and allow
for more sensitive detection of SNPs in genome-wide
association analyses. By co-varying for whole hippocampal
volume, we expected to identify associations that are spe-
ciﬁc to one or some of the subﬁelds, allowing for a more
nuanced understanding of the genetic underpinnings of this
heterogeneous structure. As such, we hoped to uncover
results that inform us about the individual, differing, bio-
logical functions of the subﬁelds more than what would
have been achieved by correcting solely for intracranial
volume (ICV). In addition, utilizing summary statistics from
previous large-scale GWAS, we sought to characterize the
genetic overlap amongst the volumes of the subﬁelds, with
other subcortical and cortical regions, and with a diagnosis
of schizophrenia or AD.
Materials and methods
Participants
We included data from 16 cohorts that had structural MRI
and genome-wide genotypes available, listed in Supple-
mentary Table S1, amounting to a total sample size of
21,297 individuals. The age range of the sample covered a
large part of the lifespan (mean age 47.8 years, SD 17.3,
range 3.2–91.4) and 48.3% was male. Information on
individual cohorts, including brain disorder diagnoses (n=
1464, 6.9% of total), is given in the Supplementary Infor-
mation (SI), together with ﬁgures illustrating the distribu-
tions of demographics and their relation with hippocampal
volume. Each sample was collected with the participants’
written informed consent and with approval by local Insti-
tutional Review Boards.
MRI data processing
Extended information on MRI data handling, including
processing and scan quality control (QC), is given in the SI.
Brieﬂy, T1-weighted MRI volumes were processed using
the standard FreeSurfer recon-all stream (v.5.3, http://surfer.
nmr.mgh.harvard.edu). Hippocampal subﬁeld volume esti-
mates were subsequently obtained by running the novel
subﬁeld segmentation algorithm that was released as part of
FreeSurfer v6.0. This algorithm employs Bayesian infer-
ence in combination with a hippocampal atlas created
through manual delineation of ultra-high resolution (0.13
mm) images of ex vivo hippocampal tissue [5]. As a
robustness analysis, assessing the inﬂuence of FreeSurfer
version used in the initial reconstruction, we reran the main
segmentation (recon -all -all) using FreeSurfer v6.0 instead
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of v5.3 for 50 participants. We then calculated the corre-
lation between hippocampal subﬁeld volume estimates
obtained through the combination of FreeSurfer v5.3 and
the v6.0 hippocampal segmentation algorithm with those
obtained when FreeSurfer v6.0 was also used for the main
segmentation. These correlations ranged from 0.87 for the
parasubiculum to 0.96 for the hippocampal tail, as more
thoroughly described in the SI.
Genotyping and quality control
Genetic data were obtained at each site using commercially
available genotyping platforms. We carried out phasing and
imputation according to protocols in line with those applied
by the ENIGMA consortium (http://enigma.ini.usc.edu),
applying standard QC settings, further described in the SI.
Following conventional GWAS practices, the genetic ana-
lyses were restricted to participants of European ancestry, as
determined through multidimensional scaling (MDS). This
was done in order to reduce heterogeneity and prevent false
positives/negatives due to imputation inaccuracies and
allele frequency deviations within the relatively small non-
European and mixed-ancestry subsample [22, 23].
Statistical analyses
All code used for carrying out the described analyses is
available upon request from the corresponding author. We
included all 12 subﬁelds as outcome measures in the ana-
lyses, approximately from anterior to posterior: the para-
subiculum, presubiculum, subiculum, CA ﬁelds 1, 2/3 and 4
(henceforth referred to as CA1, CA3 and CA4), granule cell
layer of the DG, hippocampus–amygdala–transition area,
ﬁmbria (a white matter structure), the molecular layer of the
DG, hippocampal ﬁssure and the hippocampal tail. We
deﬁned whole hippocampal volume as the sum of all
structures minus the hippocampal ﬁssure. As the volumetric
and genetic correlations between both hemispheres were
extremely high for all structures (nearly all > 0.90), we
summed the estimates of both hemispheres together to
reduce the number of analyses.
Before all analyses, we regressed out the effects of scan-
ning sites, sex, brain disorder diagnosis, age and ICV from
each outcome measure. This was done through generalized
additive model (GAM)-ﬁtting in R (v2.4.0) on the total
sample, estimating each outcome measure from these vari-
ables, and extracting the residuals. We further removed all
individuals ± 4 SD from the mean on any of the hippocampal
measures or ICV (n= 143, i.e., 0.67% of the total sample).
To correct for the multiple comparisons, we calculated
the degree of independence between the volume estimates
of the subﬁelds plus whole hippocampus, by generating a
13 × 13 correlation matrix based on the Pearson’s
correlation between all pair-wise combinations. Based on
the ratio of observed eigenvalue variance to its theoretical
maximum, the estimated equivalent number of independent
traits in our analyses was 7.70. We therefore divided the
community standard [24] nominal genome-wide sig-
niﬁcance threshold of 5 × 10−8 by this number, setting a
threshold of 6.5 × 10−9.
Genome-wide complex trait analyses
We used genome-wide complex trait analysis (GCTA) [25]
to calculate SNP-based heritability of each of the GAM-
residualized subﬁeld volume estimates, as well as those of
other subcortical regions and cerebral lobes produced by
FreeSurfer’s subcortical [26] and cortical segmentation [27]
streams. We additionally included the ﬁrst four population
components, calculated through MDS on the entire sample,
as covariates to guard against ethnicity effects. GCTA
employs a restricted maximum likelihood (REML)
approach, ﬁtting the effects of all common SNPs as random
effects by a mixed linear model, to obtain an estimate of the
proportion of phenotypic variance explained by genome-
wide SNPs. We further applied bivariate REML to estimate
the genetic correlation between all regions [28]. Before the
analysis, we removed regions with high linkage dis-
equilibrium (LD) from the genetic data and pruned it, using
a sliding window approach with a window size of 50, a step
size of 5 and an R2 of 0.2, leaving 133,147 SNPs. The
Brain Imaging Genetics cohort was not included in these
analyses, as we did not have the genetic data in-house; the
sample size for these analyses was therefore n= 18,979.
Genome-wide association analyses
We performed GWAS using PLINK. We chose a meta-
analysis over a mega-analysis design to minimize batch
effects from the cohorts, which differed in terms of mean
age and other aspects of their recruitment, with virtually no
loss in statistical efﬁciency [29]. We ﬁrst carried out a
GWAS within each sample for the GAM-residualized
estimates of the volume of the whole hippocampus and
each of the 12 subﬁelds. We included the ﬁrst four popu-
lation components, calculated through MDS within each
sample, as covariates. For the subﬁelds, we also included
whole hippocampal volume as a covariate. This was done to
allow for the identiﬁcation of associations that may be more
speciﬁc to one or some of the subﬁelds. For transparency
and comparison with previous studies, we also performed a
second set of GWAS for the subﬁelds without whole hip-
pocampal volume as a covariate, the results of which are
reported in the SI. For each GWAS, we subsequently
combined the within-sample results using a ﬁxed-effect,
inverse variance-weighted, meta-analysis in PLINK.
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In order to assess to what degree the reported associa-
tions between SNPs and hippocampal volume were driven
by the inclusion of clinical samples, we re-analysed the data
excluding individuals with brain disorders (n= 1464, 6.9%
of the total sample size used in the main genome-wide
association analyses). The regression coefﬁcients for SNPs
with P < 1 × 10−5 (13,867 SNPs) from the main genome-
wide analysis on whole hippocampal volume, including
patients, were highly correlated with the regression coefﬁ-
cients from the analysis excluding patients (Pearson’s r=
0.87).
Functional annotation
We used the Functional Mapping and Annotation of
Genome-Wide Association Studies (FUMA) platform for
functional annotation of the GWAS results [30]. Through
the SNP2GENE function, signiﬁcant SNPs were mapped to
genes based on positional, expression quantitative trait loci,
and chromatin interaction information from 18 biological
data repositories and tools integrated into FUMA. The
resulting set of prioritized genes was checked for over-
representation in gene sets of biological processes and
GWAS catalogues with the GENE2FUNC function, using a
hypergeometric test.
Genetic overlap with AD and schizophrenia
We applied cross-trait LD score regression (LDSR) [31] and
conditional false discovery rate (FDR) analysis [32, 33] to
investigate the genetic overlap of each of the subﬁelds with
schizophrenia and AD. For this, we used the summary
statistics from the 2014 PGC2 schizophrenia GWAS [34]
and the 2013 IGAP AD GWAS [35]. Each set of summary
statistics underwent additional ﬁltering, including the
removal of all SNPs in the extended major histocompat-
ibility complex region (chr6:25–35Mb) and the use of only
Caucasian samples. We further minimized sample overlap
by rerunning the hippocampal subﬁeld GWAS without the
ADNI (Alzheimer’s Disease Neuroimaging Initiative)
cohorts for comparison with the AD GWAS, and by
removing the Thematically Organized Psychosis and
HUman Brain INformatics cohorts from the schizophrenia
GWAS. For further explanation of these two techniques, see
the SI.
Results
SNP-based heritability
The SNP-based heritability of each subﬁeld’s volume esti-
mate as well as additional regions of interest and the genetic
correlations between them are shown in Fig. 1. The herit-
ability estimates for all subﬁelds, displayed on the plot’s
diagonal, were highly signiﬁcant (all p-values < 1 × 10−16),
ranging from h2= 0.14 of the parasubiculum to h2= 0.27
for the hippocampal tail. Full test statistics of the heritability
estimates for all regions are listed in Table S2. Based on
their genetic correlations, most of the hippocampal subﬁelds
formed a cluster, which further included the amygdala. The
cortical grey matter volumes of the cerebral lobes clustered
together, as did the pallidum, caudate and putamen, i.e.,
basal ganglia structures.
Genome-wide association analyses
Our GWAS of whole hippocampal volume identiﬁed eight
whole-genome signiﬁcant loci. Of these, three loci have not
been associated with the hippocampus before, namely those
with lead SNP rs7630893 at chromosome 3 within the
TFDP2 gene, lead SNP rs2303611 within the FAM175B
gene at chromosome 10 and rs1419859 at chromosome 12
upstream of PARP11.
The GWAS per subﬁeld, corrected for whole hippo-
campal volume, identiﬁed a total of ten unique loci over six
subﬁelds. Of these ten, seven were not found for the GWAS
on whole hippocampal volume. See Table 1 for information
on each of the lead SNPs, per structure. Figure 2 provides
an overview of the distribution of the p-values per top hit
over the subﬁelds, showing that although some have global
effects, others are driven by speciﬁc subﬁelds, most pro-
minently the hippocampal tail. QQ plots and Manhattan
plots for all subﬁelds are shown in Figure S3. Forest plots
indicated that all of the lead SNPs showed comparable
effect sizes across the majority of cohorts, shown in
Figure S4.
The set of GWAS on the subﬁelds without co-varying
for whole hippocampal volume identiﬁed a total of 35
loci over ten subﬁelds. See Table S4 for an overview of
these loci.
Functional annotation
The location of the genome-wide signiﬁcant loci, in com-
bination with the LD structure and known biological con-
sequences of variation in these regions, led to the
prioritization of 24 genes, listed in Table 2 next to the loci
that mapped onto them. Hypergeometric tests indicated that
the lists of genes identiﬁed through the GWAS for both the
volume of the whole hippocampus and the hippocampal tail
were signiﬁcantly enriched for genes associated with loco-
motive and exploratory behaviour. Further comparison with
GWAS catalogues showed signiﬁcant enrichment of AD-
related genes for whole hippocampal volume, the hippo-
campal tail showed enrichment for schizophrenia-related
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genes and the molecular layer was enriched for inﬂamma-
tory bowel disease.
Genetic overlap with AD and schizophrenia
Through LDSR, we found no signiﬁcant evidence for
genetic overlap of any of the hippocampal subﬁelds with
either disorder, as listed in Table S4. The conditional QQ
plots did show enrichment as a function of association with
schizophrenia for the presubiculum and subiculum, illu-
strated in Fig. 3. This is not seen for other subﬁelds, nor
when conditioning on AD (see Figure S5). The subsequent
conjunctional FDR analysis for these two subﬁelds identi-
ﬁed respectively ﬁve and four loci overlapping with
Fig. 1 Correlation matrix of the volume estimates for the subﬁelds as
well as several other cortical and subcortical regions of interest and
cerebral lobes. All correlations are multiplied by a factor 100. The
volumetric correlations are shown in the lower triangle of the matrix
(green–orange), the heritability estimates on the diagonal, and the
genetic correlations in the upper triangle (blue–red). The order, indi-
cated by the dendrogram on top, is determined by hierarchical clus-
tering using Ward’s D2 method
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Table 1 Whole-genome signiﬁcant loci for whole hippocampal volume as well as for the subﬁelds while co-varying for whole hippocampal
volume
Structure Unique
locus
Lead SNP A1 Chr Position (BP) Beta† P-value Mapped gene(s) GWAS
catalogue
Whole
hippocampus
1 rs1861979 T 2 162845565 39.54 4.64e− 13 SLC4A10, DPP4 [19, 34, 37–39]
2 rs7630893 C 3 141759380 36.18 2.55e− 09 ATP1B3, TFDP2 [60–62]
3 rs57246240 A 5 66112715 36.63 9.00e− 11 MAST4 [19]
4 rs7873551 C 9 119245127 -42.42 3.51e− 11 ASTN2 [19, 47–50, 73]
5 rs12218858 C 10 126474200 43.75 1.06e− 15 FAM175B, FAM53B,
METTL10
[53, 54]
6 rs1419859 T 12 4007898 − 35.60 1.01e− 09 PARP11 -
7 rs17178139 A 12 65765944 − 58.08 1.58e− 20 WIF1, LEMD3, MSRB3 [18, 19, 73–75]
8 rs77956314 C 12 117323367 123.31 2.19e− 35 RNFT2, HRK, FBXW8,
TESC
[17–19, 73]
Presubiculum 7 rs17178006 G 12 65718299 5.61 1.83e− 15 WIF1, LEMD3, MSRB3 [18, 19, 73–75]
Subiculum 9 rs9399619 G 6 148056480 2.31 5.87e− 09 SAMD5 -
CA1 7 rs17178006 G 12 65718299 − 6.48 7.76e− 19 WIF1, LEMD3, MSRB3 [18, 19, 73–75]
10 rs160459 C 14 59074136 2.98 1.98e− 10 DACT1 -
Dentate gyrus 10 rs160459 C 14 59074136 1.53 2.04e− 09 DACT1 -
Molecular layer 5 rs4962694 G 10 126436717 − 1.36 3.75e− 12 FAM175B, FAM53B,
METTL10
[53, 54]
Hippocampal tail 11 rs6675690 G 1 47945370 7.31 7.66e− 12 -
12 rs10888696 A 1 51016603 5.22 4.04e− 10 DMRTA2, FAF1, CDKN2C -
1 rs2909443 G 2 162846439 6.11 3.08e− 13 SLC4A10, DPP4 [34, 37, 39, 73]
13 rs13188633 T 5 81929360 − 5.74 7.65e− 10 -
14 rs10474356 G 5 90816402 − 7.11 9.67e− 15 -
15 rs55736786 T 5 93094118 − 8.59 3.23e− 09 FAM172A, POU5F2 -
10 rs160459 C 14 59074136 − 7.45 1.53e− 17 DACT1 -
† mm3 volume, additive effects for each copy of allele 1 (A1). BP base pair, Chr chromosome
Fig. 2 Heatmap based on the results from the genome-wide association
analyses, showing the p-value for each of the lead SNPs reported in
Table 2 (on the y axis) per subﬁeld (on the x axis) volume. High −
log10 p-values are shown in red, low values in yellow. Three stars in a
ﬁeld indicate the SNP reached whole-genome signiﬁcance for that
SNP (6.5 × 10−9), two stars nominal signiﬁcance (5 × 10−8) and one
star suggestive signiﬁcance (1 × 10−6)
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schizophrenia, described in Table 2. It is noteworthy that
three out of nine hits have opposite direction of effects
between subﬁeld volume and schizophrenia, whereas the
other six show the same direction of effects.
Following the lack of ﬁndings on genetic overlap
between AD and the hippocampal measures, the char-
acteristic age-related susceptibility and late onset of AD led
us to hypothesize that AD-related genes may show differ-
ential associations with the hippocampal structure across the
lifespan, and in particular inﬂuence hippocampal volume
later in life. To test this, we investigated the association
between hippocampal volume and 12 whole-genome sig-
niﬁcant loci from the discovery phase of the IGAP 2013 AD
GWAS in a young and older subsample based on a median
split (below and above 53.9 years of age, n= 9055 in each
group after excluding those individuals that were part of the
AD GWAS). We found that none of these SNPs were sig-
niﬁcantly associated with hippocampal volume in the
younger age group, whereas three of them were signiﬁcant
in the older age group. See the SI for more information on
these analyses and Table S6 for the full results.
Discussion
The hippocampus complex comprises structurally and
functionally distinct subﬁelds with critical yet differential
involvement in a range of behaviours and disorders. Using
brain scans from 21,297 individuals, we showed that dif-
ferences in the cytoarchitecture of the subﬁelds, providing
the basis for their segmentation [5], are partly driven by
differences in their genetic architecture. Further, greater
speciﬁcity in the phenotypes under investigation allowed
for the discovery of speciﬁc genetic variants. The elucida-
tion of their genetic architecture and identiﬁcation of spe-
ciﬁc genetic variants should be helpful in better
understanding the biological functions of the individual
subﬁelds and their role in the development of common brain
disorders.
The SNP-based heritability estimates we obtained, ran-
ging from 0.1 to 0.3, were comparable to those reported in
previous large-scale studies of the narrow-sense heritability
of subcortical structures, when corrected for ICV [20]. They
also agree with ﬁndings from twin studies, showing that the
larger subﬁelds are the most heritable [21]. We further
found that the genetic correlations broadly mirror the
volumetric correlations, and that the subﬁelds cluster toge-
ther with the amygdala. The strength of the correlations
indicates that these structures share much of their genetic
determinants, yet also conﬁrm that they do indeed have
speciﬁc, individual inﬂuences. Our estimates of genetic
correlations with other structures corroborate ﬁndings from
a twin study that identiﬁed the same genetic clusters, with
the hippocampus and amygdala clustering separately
from respectively the cerebral lobes and basal ganglia
structures [36].
The genome-wide association analyses per subﬁeld
supported our reasoning that greater phenotypic speciﬁcity
may aid genetic discoverability; we identiﬁed several
genetic variants related to the volumes of the subﬁelds
above and beyond whole hippocampal volume. We found
ﬁve out of six loci reported by a recent ENIGMA hippo-
campal GWAS and the pattern of effects across the sub-
ﬁelds also largely agree with their supplementary analyses
of these top hits [19]. This included a locus at chromosome
2, which maps onto the SLC4A10 and DPP4 genes, with
our subﬁeld analyses indicating this is driven by its effect
on hippocampal tail volume. This locus has also been found
in GWAS of educational attainment [37], cognitive ability
[38] and schizophrenia [34, 39]. Further, inhibitors of DPP4
have been shown to improve recognition memory, lower
oxidative stress and increase hippocampal neurogenesis in
rodents [40, 41]. The well-known locus at chromosome 12
in the MSRB3 gene [17, 18, 36], on the other hand, appears
to be mostly driven by its effect on more anterior regions,
being associated with the presubiculum and CA1. MSRB3, a
gene involved in anti-oxidant reactions, has recently been
shown to be particularly important for pyramidal neurons
Table 2 Results from the
conjunctional false discovery
rate (FDR) analysis of the
presubiculum and subiculum
GWAS summary stats with
those from the schizophrenia
GWAS, identifying shared loci
at a conjunctional FDR < 0.05
Subﬁeld Locus SNP A1 Chr Position (BP) Gene Z-score
subﬁeld
Z-score
schizophrenia
Presubiculum 1 rs3790598 G 1 113196896 CAPZA1 − 4.37 3.63
2 rs6427128 A 1 155026942 ADAM15 − 5.23 3.70
3 rs7766356 T 6 28400538 ZSCAN23 − 4.20 8.16
4 rs2554862 C 12 51202046 ATF1 − 3.97 − 3.52
5 rs9966779 C 18 53620456 AK057336 3.72 4.85
Subiculum 1 rs11584070 A 1 150294925 PRPF3 4.57 4.54
2 rs13107325 C 4 103188709 SLC39A8 − 4.17 − 6.27
3 rs10087493 C 8 8373557 PRAGMIN − 4.11 − 3.87
4 rs3114896 T 16 89393562 ANKRD11 − 4.18 − 4.09
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speciﬁcally in CA1 and to have lowered expression in the
hippocampi of individuals with AD [42]. The other locus on
chromosome 12, linked to the HRK gene, appears to have a
global effect, not being linked to any of the subﬁelds after
correction for whole hippocampal volume. HRK is a pro-
apoptotic gene associated with several forms of cancer [43]
and reported in one GWAS of AD age of onset [44]. The
two remaining replications at chromosome 5 and 9 within
the MAST4 and ASTN2 genes also only appear for whole
hippocampal volume. MAST4 codes for a microtubule
protein part of the serine/threonine kinase family, with
differential expression in frontotemporal dementia [45].
ASTN2 is thought to have a role in neuronal migration [46].
It has been repeatedly associated with migraine [47–50], as
well as schizophrenia [51] and other neurodevelopmental
disorders [52].
The novel loci we identiﬁed may contribute to under-
standing the relation between certain peripheral diseases
and cognitive dysfunction. The locus at chromosome 10,
within the FAM175B gene, has been previously associated
with cocaine dependence [53] and bronchodilator respon-
siveness [54], as well as being reported in a recent GWAS
of inﬂammatory bowel disease [55]. Beyond whole hippo-
campal volume, it was found for the molecular layer of the
DG and the hippocampal tail, i.e., more posterior regions of
the hippocampus. In rodents, lesions to the dorsal (corre-
sponding to posterior in humans), but not ventral, hippo-
campus disrupt cocaine craving [56, 57] and cocaine
administration lowers neurogenesis in the DG [58]. Chronic
intestinal inﬂammation has been associated with altered
hippocampal neurogenesis, which has been theorized to
explain the link between this disease and cognitive dys-
function [59]. Another novel locus, at chromosome 3, lies
within the TFDP2 gene. This gene, with a function in cell
proliferation, is well-known for its relation with kidney
dysfunction [60–62]. Chronic kidney dysfunction in turn is
associated with cognitive impairment and hippocampal
atrophy [63].
Several genes were implicated through the GWAS on the
subﬁelds that were not identiﬁed for whole hippocampal
volume, illustrating the value of studying more speciﬁc
phenotypes. Through the GWAS on the hippocampal tail,
we found a locus at chromosome 1 with lead SNP
rs4926555, within the FAF1 gene. The protein product of
this gene regulates neuronal cell survival and apoptosis
[64], as well as glucocorticoid receptor-mediated tran-
scription in hippocampal cells [65]. The GWAS on the
granule cell layer of the DG and hippocampal tail further led
to the identiﬁcation of a novel locus at chromosome 14 with
lead SNP rs160459, mapped to the DACT1 gene. Knockout
of DACT1 has been shown to lead to decreased dendrite
complexity in cultured hippocampal pyramidal neurons [66]
and its expression has been linked to tumorigenesis sup-
pression [67].
Greater speciﬁcity in hippocampal segmentation also
proved to be valuable for the investigation of genetic
overlap with brain disorders. Through conditional FDR, we
found signs of pleiotropy between schizophrenia and the
subiculum and presubiculum, but not for other subﬁelds.
This is in line with studies showing that these anterior
subﬁelds are disproportionately affected in patients with
ﬁrst-episode schizophrenia [9]. Such a distinction may
Fig. 3 QQ plots of the p-values from the presubiculum and subiculum
genome-wide association studies (GWAS), conditioned on those from
a schizophrenia GWAS. For both subﬁelds, there is a clear upward
deﬂection from the expected p-value distribution (in grey) that
strengthens with increasing thresholds; the black line reﬂects the
distribution of p-values from the subﬁelds with no schizophrenia
p-value threshold, blue shows the distribution of p-values remaining at
a threshold of p < 0.1, purple those at a threshold of p < 0.01 and red
those at p < 0.001
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indicate that the relation between the subicular regions and
schizophrenia is more genetically driven, whereas the glo-
bal reduction of hippocampal volume seen in later disease
stages is relatively stronger inﬂuenced by environmental
factors and the disease process. The subsequent conjunc-
tional FDR analyses pinpointed some speciﬁc loci that
overlapped, including SLC39A8, a gene well-known for its
high pleiotropy [68], being linked to a range of traits
besides schizophrenia, including cognitive functioning [69].
These analyses also indicated that while some lead SNPs
had opposing direction of effects on subﬁeld volume versus
schizophrenia, others had the same direction. These mixed
directions of effects are indicative of a complex aetiology
underlying the well-documented relationship between this
disorder and hippocampal volume reductions. This may
contribute to the scarcity of ﬁndings on most global tests of
genetic overlap [20], including our own LDSR analyses, as
mixed directions of effects may cancel each other out. We
further found no evidence of pleiotropy between AD and
any subﬁeld in these analyses, despite the strong involve-
ment of the hippocampus in this disorder. Follow-up ana-
lyses on age-stratiﬁed subsamples revealed that several top
hits from an AD GWAS were signiﬁcantly associated with
hippocampal volume only in the older group, agreeing with
our hypothesis that AD-related genes may inﬂuence hip-
pocampal volume predominantly later in life. This strongly
advocates for the use of age as a moderating factor in
genetics studies. Our pattern of ﬁndings once again illus-
trates the complexity of the genetic relationships between
neuroimaging measures and disorders.
Although our results are encouraging, future genetics
studies may beneﬁt from optimization of the subﬁeld seg-
mentation approaches. The segmentation algorithm
employed here is based on an atlas created using histolo-
gical and morphometric features [5]. Gene expression stu-
dies of the hippocampus have indicated that there are
numerous genetic domains with clearly demarcated borders
that only partly overlap with this subﬁeld division [16]. We
also found that the six subﬁelds with signiﬁcant loci were
also the six largest subﬁelds, i.e., subﬁeld size appears
positively correlated with discoverability of genetic var-
iants. This pattern of ﬁndings likely partly reﬂects that the
larger subﬁelds are segmented with greater accuracy [21].
Our large age-span should also be noted in this regard, as it
is currently unclear how well FreeSurfer processes scans
from very young children [70]. Future studies may beneﬁt
from use of higher resolution data and/or the combination
with T2-weighted images to improve segmentation accu-
racy [5]. Lastly, comparison of results with the literature is
hindered by the differences in subﬁeld deﬁnitions being
used, harmonization is needed [71] to further improve dis-
coverability [72].
In conclusion, in addition to providing information on
the localization of the effects on the hippocampus for pre-
viously identiﬁed genetic variants, we identiﬁed novel
variants that inﬂuenced speciﬁc subﬁelds. These variants
were not previously associated with hippocampal volume,
yet have known roles in neuronal differentiation and neu-
rodevelopmental disorders. Together with the estimated
genetic correlations, we have shown that hippocampal
subﬁelds have partly distinct genetic determinants, asso-
ciated with speciﬁc biological processes and traits, thereby
providing evidence that there is value in greater speciﬁcity
of the brain phenotypes under investigation. Taking into
account, this speciﬁcity may aid in furthering our under-
standing of hippocampal neurobiology and associated
functions and disorders.
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